Fig. 2.
Mean plasma oxycodone concentrations following intranasal dosing over time in the full analysis set. OC-F finely crushed original formulation of oxycodone-HCl controlled release, ORF-C coarsely crushed reformulated oxycodone-HCl controlled release, ORF-F finely crushed reformulated oxycodone-HCl controlled release